The TRACER research starts with the patient. Sickle cell anemia and Diamond-Blackfan anemia are diseases that disrupt the lives of millions of people around the world. Sickle cell anemia is an inherited disorder causing red blood cells to take on a sickle or crescent moon shape. This leads to reduced oxygen flow, pain, and organ damage.
Diamond-Blackfan anemia is a rare genetic condition hindering red blood cell production in the bone marrow. This results in various health complications such as anemia, fatigue and pale skin. Other symptoms may include slow growth, skeletal abnormalities, and other congenital anomalies.
Both conditions significantly impact patients' well-being. Through stem cell research, the TRACER consortium aims to find new solutions to treating and curing patients from these hereditary blood diseases. TRACER involves patients, families of patients and patient organizations in shaping these new solutions.
